A US Food and Drug
Administration advisory panel has
voted to ease current restrictions
on the use of GlaxoSmithKline’s
Avandia (rosiglitazone) for the
treatment of type 2 diabetes.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 07 Jun 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Jun 13
HIGH rates of unnecessary prescribing reported in the Australian Institute of Health and Welfare (AIHW) Australia’s Health 2018 report highlights the need for greater integration of pharmacists in medication management roles, the Pharmaceutical Society of Australia (PSA) believes.
A PHARMACIST who self-supplied prescription medications and altered dispensing records has avoided suspension at a Victorian Civil and Administrative Tribunal.
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.